As such, interventions in either mothers or fathers may have favourable impacts on foetal SIRT1 regulation and the associated metabolic pathways, hence reducing the risk of developing obesity and metabolic disorders such as type 2 diabetes and non-alcoholic fatty liver disease. The gene discussed is SIRT1; the disease is obesity disorder.